- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
Biopharmaceutical company Seaport Therapeutics announced the appointment of Lana Gladstein as general counsel.
Most recently, Gladstein was the group general counsel at APRINOIA Therapeutics. Her prior roles include chief legal officer at Recipharm; chief legal officer and general counsel at Arranta Bio; and executive vice president, general counsel, and officer at Brammer Bio.
Compliance Week accepts outside contributions from corporate chief compliance officers and other senior-level GRC practitioners. To learn more, contact the CW Editor.
Three months after a U.S. district judge declared Google to be running a monopoly, the Department of Justice recommended the tech giant be forced to sell off its popular Chrome browser as part of an effort to resolve antitrust concerns and reshape the power of tech’s biggest companies.
Securities and Exchange Commission Chair Gary Gensler will step down from his position as the top U.S. regulator of Wall Street when Donald Trump is sworn in as president on Jan. 20, ending weeks of speculation about his future.
Big Tech digital payment apps will be subjected to increased oversight and requirements–similar to that of banks and credit unions–under a finalized rule by the Consumer Financial Protection Bureau.
No comments yet